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Orally acquired prions use immune compounds to arrive to the CNS and GALT has a key role in the process. DCs and FDCs constitute the greatest crucial
point, being the most exploited cells by the agent. Separately, prion uptake by M-cells is the first essential step, and would constitute an interesting
target for new therapies. As current treatment strategies involving inhibitors targeting initial uptake and accumulation of prions severely reduce disease
susceptibility, further understanding of the DC and FDC-prion interaction, and the still hypothesized invasion steps, could lead to novel therapeutic
strategies or new factors affecting the pathology.
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Prions (PrPsc) are a misfolded form of the endogenous prion protein PrPc which can cause transmissive and fatal
neurodegenerative diseases in humans. When orally acquired, first steps in prion neuroinvasion essentially depend on
exploiting secondary lymphoid organs in order to replicate and enter the enteric nervous system (ENS) to reach the
central nervous system (CNS). The gut associated lymphoid tissue (GALT) plays a key role in the process, allowing the
agent to accumulate, replicate and disseminate.
Introduction Aims
Provide an insight, from an
immunological point of view, into
what is known of the prion-cell
interaction from the intestinal
trans-epithelial crossing to prion
delivery to the ENS during
neuroinvasion, focusing on GALT
importance.
Trans-epithelial crossing
Prions need to cross the Follicular Associated Epithelium (FAE)
to reach GALT’s Peyer’s patches (PPs) and mature Isolated
Lymphoid Follicles (mILFs) (Fig. 2), where accumulation is most
relevant[1]. Caption is accomplished by M-cells and enterocytes,
where Laminin receptor (LPR/LR) - expressed in their apical
brush - may have a key role, in a PrPc independent manner;
possibly through endocytic vesicles.
Transport to Secondary Lymphoid Organs
Once in the Sub-Epithelial Dome (SED), prions delivered by M-cells will arrive
to PPs and mILFs through CD11c+ CD11b-/CD8α- CXCR5-expressing classical
Dendritic Cells (DCs), which can acquire the agent by Tunnelling Nano Tubes
(TNTs), most probably by trapping it complement-opsonized[3]. Tingible-Body
Macrophages can likewise acquire prions, allegedly from enterocytes, but
unlike DCs they might degrade them maintaining a plateau state of prion
accumulation competing with prions replicating among Follicular DCs (FDCs)[4].
FDCs in Germinal Centres (GCs) and B-cells
DCs migrate to GCs through CXCL13-CXCR5 signalling. There FCDs acquire
prions by stripping the classical-pathway-complement opsonized complexes
(where C3 and C1q are essential) from DCs - or in an indirect manner by B-cell
intermediators - [5].
FDC in GCs accumulate and replicate prions on their surfaces aided by B-cells
which provide Lymphotoxins and TNF for FDC-network maintenance and
formation of hypertrophic dendrites, which will provide an optimal
environment for prion replication: By Inducing a strong GC response by the B-
cell CD21/35) and by further presentation to other B-cells, which will
disseminate prions to non-draining LNs[6].
In MLNs where prion accumulation can be FDC independent, HEVs serve as
entry point for prion-harbouring macrophages, which are thought to
accumulate prions thanks to their inability to destroy them at high enough
titters, and B-cells which disseminate them. HEVs are maintained by LTβR
signalling, which is provided by not only B-cells but also DCs[7].
Invasion of ENS
Prions reach the CNS by invading the ENS innervating SLOs, being delivered to
nerves by DCs or FDCs[8] most probably by cell-cell contact through TNTs or by
PrPsc loaded exovesicles.
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Fig. 1[3] – Scheme of first steps in orally acquired prion neuroinvasion.
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